A field trial of alternative targeted screening strategies for chagas disease in Arequipa, Peru

PLoS Neglected Tropical Diseases

Volumn 6, Issue 1, 2012, Pages

  Hunter, Gabrielle C ^a   Borrini Mayorí, Katty ^b   Ancca Juárez, Jenny ^b   Castillo Neyra, Ricardo ^a,b   Verastegui, Manuela R ^b   Malaga Chavez, Fernando S ^c   del Cornejo Carpio, Juan Geny ^c   Córdova Benzaquen, Eleazar ^d   Náquira, César ^b   Gilman, Robert H ^a   Bern, Caryn ^e   Levy, Michael Z ^f  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b UNIVERSIDAD PERUANA CAYETANO HEREDIA   (Peru)

^c Dirección Regional del Ministerio de Salud   (Peru)

^d UNIVERSIDAD NACIONAL DE SAN AGUSTÍN DE AREQUIPA   (Peru)

^e CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^f UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGE; AGED; ARTICLE; BLOOD SAMPLING; CHAGAS DISEASE; CHILD; CROSS-SECTIONAL STUDY; DISEASE CARRIER; FEMALE; HEALTH ASSESSMENT QUESTIONNAIRE; HEALTH CARE COST; HEALTH SURVEY; HOUSEHOLD; HUMAN; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; PARASITE TRANSMISSION; PERU; PRESCHOOL CHILD; RURAL AREA; SCHOOL CHILD; SCREENING TEST; SEROLOGY; TRIATOMINAE; TRYPANOSOMA CRUZI; VECTOR CONTROL; COST BENEFIT ANALYSIS; ECONOMICS; EVALUATION; INFANT; MASS SCREENING; METHODOLOGY; MIDDLE AGED; PREVALENCE; RISK FACTOR; SELF EXAMINATION; URBAN POPULATION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHAGAS DISEASE; CHILD; CHILD, PRESCHOOL; COST-BENEFIT ANALYSIS; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; INFANT; MALE; MASS SCREENING; MIDDLE AGED; PERU; PREVALENCE; RISK FACTORS; SELF-EXAMINATION; URBAN POPULATION; YOUNG ADULT;

EID: 84856560811     PISSN: 19352727     EISSN: 19352735     Source Type: Journal    
DOI: 10.1371/journal.pntd.0001468     Document Type: Article

References (42)

1. WHO Expert Committee (2002) Control of Chagas Disease. Brasilia, Brazil: World Health Organization. pp. 1-109 WHO technical report series number 905 WHO technical report series number 905.
2. Dias JC, Silveira AC, Schofield CJ, (2002) The impact of Chagas disease control in Latin America: a review. Mem Inst Oswaldo Cruz 97: 603-612.
3. Gurtler RE, (2009) Sustainability of vector control strategies in the Gran Chaco Region: current challenges and possible approaches. Mem Inst Oswaldo Cruz 104 (Suppl 1): 52-59.
4. Herrer A, (1960) [Geographical distribution of Chagas' disease and of its vectors in Peru.]. Bol Oficina Sanit Panam 49: 572-581.
5. Herrer A, (1964) Chagas' Disease in Peru. I. The Epidemiological Importance of the Guinea Pig. Trop Geogr Med 16: 146-151.
6. Cornejo-Donayre A, Cubas E, Eyzaguire G, Dominguez P, Bitrich H, et al. (1963) Enfermedad de Chagas en el Sur del Peru. Anales de la Facultad de Medicina de Lima 46: 587-617.
7. Organizacion Panamericana de la Salud (2006) Estimacion cuantitativa de la enfermedad de Chagas en las Americas. Montevideo, Uruguay: Organizacion Panamericana de la Salud. OPS/HDM/CD/425-06 OPS/HDM/CD/425-06.
8. del Cornejo Carpio J, (2003) The Chagasic Endemic Situation in Peru. Federacion Argentina de Cardiologia, 3er Congreso Internacionl de Cardiologia por Internet.
9. Levy MZ, Bowman NM, Kawai V, Waller LA, del Cornejo Carpio JG, et al. (2006) Periurban Trypanosoma cruzi-infected Triatoma infestans, Arequipa, Peru. Emerg Infect Dis 12: 1345-1352.
10. Bowman NM, Kawai V, Levy MZ, del Cornejo Carpio JG, Cabrera L, et al. (2008) Chagas disease transmission in periurban communities of Arequipa, Peru. Clin Infect Dis 46: 1822-1828.
11. INEI Peru INdEeId, editor (2009) Censos nacionales 2007: XI de poblacion y VI de vivienda. Lima.
12. Levy MZ, Small DS, Vilhena DA, Bowman N, Kawai V, et al. (in press (2011)) Retracing micro-epidemics of Chagas disease using epicenter regression. PLoS Computational Biology.
13. Pinto Dias JC, (1995) Natural history of Chagas disease. Arq Bras Cardiol 65: 359-366.
14. Maguire JH, Hoff R, Sherlock I, Guimaraes AC, Sleigh AC, et al. (1987) Cardiac morbidity and mortality due to Chagas' disease: prospective electrocardiographic study of a Brazilian community. Circulation 75: 1140-1145.
15. Bern C, Montgomery SP, Herwaldt BL, Rassi A Jr, Marin-Neto JA, et al. (2007) Evaluation and treatment of chagas disease in the United States: a systematic review. Jama 298: 2171-2181.
16. Maguire JH, (2004) Trypanosoma. In: Gorbach S, Bartlett J, Blacklow N, editors. Infectious Diseases 2nd ed Philadelphia Lippincott, Williams & Wilkins pp. 2327-2334.
17. Magill AJ, Reed SG, (2000) American Trypanosomiasis. In: Strickland GT, editors. Hunter's Tropical Medicine and Emerging Diseases 8th ed Philadelphia, PA W.B.Saunders Company pp. 653-664.
18. Sosa-Estani S, Viotti R, Segura EL, (2009) Therapy, diagnosis and prognosis of chronic Chagas disease: insight gained in Argentina. Mem Inst Oswaldo Cruz 104 (Suppl 1): 167-180.
19. Gurtler RE, (2007) Combining Residual Insecticide Spraying Campaigns with Targeted Detection and Specific Chemotherapy for Trypanosoma cruzi Infection in Children. PLoS Negl Trop Dis 1: e168.
20. Verani JR, Seitz A, Gilman RH, LaFuente C, Galdos-Cardenas G, et al. (2009) Geographic variation in the sensitivity of recombinant antigen-based rapid tests for chronic Trypanosoma cruzi infection. Am J Trop Med Hyg 80: 410-415.
21. Dias JC, (2007) Southern Cone Initiative for the elimination of domestic populations of Triatoma infestans and the interruption of transfusional Chagas disease. Historical aspects, present situation, and perspectives. Mem Inst Oswaldo Cruz 102 (Suppl 1): 11-18.
22. Mills A, Rasheed F, Tollman S, (2006) Strengthening Health Systems. In: DT J, JG B, AR M, editors. Disease Control Priorities in Developing Countries. 2nd edition ed Washington, DC World Bank.
23. Tarleton RL, Reithinger R, Urbina JA, Kitron U, Gurtler RE, (2007) The challenges of Chagas Disease-grim outlook or glimmer of hope. PLoS Med 4: e332.
24. Abad-Franch F, Santos WS, Schofield CJ, Research needs for Chagas disease prevention. Acta Trop 115: 44-54.
25. Vazquez-Prokopec GM, Spillmann C, Zaidenberg M, Kitron U, Gurtler RE, (2009) Cost-effectiveness of chagas disease vector control strategies in Northwestern Argentina. PLoS Negl Trop Dis 3: e363.
26. Wilson LS, Ramsey JM, Koplowicz YB, Valiente-Banuet L, Motter C, et al. (2008) Cost-effectiveness of implementation methods for ELISA serology testing of Trypanosoma cruzi in California blood banks. Am J Trop Med Hyg 79: 53-68.
27. Agapova M, Busch MP, Custer B, (2010) Cost-effectiveness of screening the US blood supply for Trypanosoma cruzi. Transfusion 50: 2220-2232.
28. Pirard M, Iihoshi N, Boelaert M, Basanta P, Lopez F, et al. (2005) The validity of serologic tests for Trypanosoma cruzi and the effectiveness of transfusional screening strategies in a hyperendemic region. Transfusion 45: 554-561.
29. Mott KE, Lehman JS Jr, Hoff R, Morrow RH, Muniz TM, et al. (1976) The epidemiology and household distribution of seroreactivity to Trypanosoma cruzi in a rural community in northeast Brazil. Am J Trop Med Hyg 25: 552-562.
30. Gurtler RE, Kitron U, Cecere MC, Segura EL, Cohen JE, (2007) Sustainable vector control and management of Chagas disease in the Gran Chaco, Argentina. Proc Natl Acad Sci U S A 104: 16194-16199.
31. Levy MZ, Kawai V, Bowman NM, Waller LA, Cabrera L, et al. (2007) Targeted Screening Strategies to Detect Trypanosoma cruzi Infection in Children. PLoS Negl Trop Dis 1: e103.
32. Levy MZ, Bowman NM, Kawai V, Plotkin JB, Waller LA, et al. (2009) Spatial patterns in discordant diagnostic test results for Chagas disease: links to transmission hotspots. Clin Infect Dis 48: 1104-1106.
33. Rothman KJ, Greenland S, Lash TL, (2008) Modern epidemiology Philadelphia Wolters Kluwer Health/Lippincott Williams & Wilkins, x, 758.
34. Barros AJ, Hirakata VN, (2003) Alternatives for logistic regression in cross-sectional studies: an empirical comparison of models that directly estimate the prevalence ratio. BMC Med Res Methodol 3: 21.
35. Briceno-Leon R, Mendez Galvan J, (2007) The social determinants of Chagas disease and the transformations of Latin America. Mem Inst Oswaldo Cruz 102 (Suppl 1): 109-112.
36. Mott KE, Desjeux P, Moncayo A, Ranque P, de Raadt P, (1990) Parasitic diseases and urban development. Bull World Health Organ 68: 691-698.
37. Bayer AM, Hunter GC, Gilman RH, del Cornejo Carpio JG, Naquira C, et al. (2009) Chagas disease, migration and community settlement patterns in Arequipa, Peru. PLoS Negl Trop Dis 3: e567.
38. Schuurman F, (1986) John Turner revisited: an intra-urban migration model for colonial type cities in Latin America. Tijdschrift voor economische en sociale geografic 77: 10.
39. Guhl F, Restrepo M, Angulo VM, Antunes CM, Campbell-Lendrum D, et al. (2005) Lessons from a national survey of Chagas disease transmission risk in Colombia. Trends Parasitol 21: 259-262.
40. O'Brien SF, Chiavetta JA, Fan W, Xi G, Yi QL, et al. (2008) Assessment of a travel question to identify donors with risk of Trypanosoma cruzi: operational validity and field testing. Transfusion 48: 755-761.
41. Mendoza Ticona CA, Cordova Benzaquen E, Ancca Juarez J, Saldana Diaz J, Torres Choque A, et al. (2005) [The prevalence of Chagas' disease in puerperal women and congenital transmission in an endemic area of Peru]. Rev Panam Salud Publica 17: 147-153.
42. Delgado S, Castillo Neyra R, Quispe Machaca VR, Ancca Juarez J, Chou Chu L, et al. (in press) A history of Chagas disease tramission, control and re-emergence in peri-rural La Joya, Peru. PLoS Negl Trop Dis.